Alla Zamarayeva, CellFE CEO

Ex­clu­sive: CellFE rais­es $22M Se­ries A to ad­vance a new cell ther­a­py man­u­fac­tur­ing idea

The Cal­i­for­nia-based start­up CellFE has raised a $22 mil­lion Se­ries A to ad­vance a new ap­proach to mak­ing cell ther­a­pies with mi­croflu­idics.

Most cell ther­a­py …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.